Increased demand for propofol injection due to the COVID-19 pandemic has led to reported shortages and limited supply of this product in Canada. Given the medical necessity of propofol injection and increased demand to manage critically ill patients needing ventilation support, Health Canada has added Propoven 2% (propofol 20 mg/mL), 100 mL Emulsion for injection or infusion to the List of Drugs for Exceptional Importation and Sale , as an interim measure to help mitigate the shortage.